My research interests have focused on molecular mechanisms of innate immune cell apoptosis in the context both of chronic inflammatory lung disease and of host defence against bacterial infection. These are areas of major therapeutic challenge with no effective therapies for persistent neutrophilic inflammation and with strategies to manipulate host immune responses to pathogens having exciting potential for treatment of antibiotic-resistance infection.